http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H1180198-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a521cfa321c963978df8ae98a84056a |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate | 1997-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53aadd87c6b58a1c7f3e34b3345532f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e9a6a0301136758ecad4107099fbb46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af21938c1de4f91114adca7bfcb90070 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45d7ae9216eb9e292bf79219c5dd1faa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6ca89e482f94b959091671e3ab9e828 |
| publicationDate | 1999-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H1180198-A |
| titleOfInvention | Monoclonal antibody, hybrid cell, and method for producing monoclonal antibody that specifically recognizes dihydropyridine structure |
| abstract | (57) [Summary] [PROBLEMS] A monoclonal antibody whose specific recognition site is specified at the molecular structure level and which can surely recognize a substance correlated with oxidative stress in vivo, such as clinical diagnosis and analysis. A monoclonal antibody useful in the above, a hybrid cell capable of producing the monoclonal antibody, and a method for producing the monoclonal antibody. The monoclonal antibody specifically recognizes a dihydropyridine structure. The monoclonal antibody is prepared by fusing antibody-producing cells and myeloma cells obtained from a constant-temperature animal immunized with a malondialdehyde-modified protein, preferably a protein consisting of malondialdehyde-modified limpet hemocyanin, as an antigen. Then, a hybrid antibody is prepared, and a monoclonal antibody that specifically recognizes a dihydropyridine structure is produced from the hybrid cell. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8309056-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7964177-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007083632-A1 |
| priorityDate | 1997-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.